Aristotle Voineskos
Centre for Addiction and Mental Health · Centre for Addiction & Mental Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aristotle Voineskos as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:29 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05531591 · RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)Centre for Addiction and Mental Health · completed · Depression, Dementia, Mild Cognitive Impairment · principal investigator
- N/ANCT05204940 · Longitudinal Observational Biomarker StudyCentre for Addiction and Mental Health · completed · Depression, Dementia, Mild Cognitive Impairment · principal investigator
- N/ANCT04418011 · Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum DisordersCentre for Addiction and Mental Health · completed · Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders · principal investigator
- N/ANCT03919760 · Early Psychosis Intervention - Spreading Evidence-based TreatmentCentre for Addiction and Mental Health · completed · First Episode Psychosis, Schizophrenia, Childhood, Psychosis · principal investigator
- N/ANCT01880255 · rTMS for Working Memory Deficits in SchizophreniaCentre for Addiction and Mental Health · completed · Schizophrenia, Schizoaffective Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- 1/5 Biomarkers to Enhance Early Schizophrenia Treatment (BEEST)R01MH134889 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2024 to 2026 · $289,948 awarded in 2026Same name and institution; not confirmed by an ID
- Neuromodulation of Social Cognitive Circuitry in People with Schizophrenia Spectrum DisordersR61MH120188 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2020 to 2022 · $368,514 awarded in 2022Same name and institution; not confirmed by an ID
- 1/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment-resistant late-life depressionR01MH114970 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2017 to 2021 · $410,356 awarded in 2021Grant number is on one of their registry trials
- 1/3 - Social Processes Initiative in Neurobiology of the Schizophrenia(s)R01MH102324 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2014 to 2018 · $306,395 awarded in 2018Same name and institution; not confirmed by an ID
- Effects of Maintenance Treatment with Olanzapine vs. Placebo on Brain StructureR01MH099167 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2013 to 2017 · $185,316 awarded in 2017Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- 2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.R01MH114980 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Patrick J Brown, BRET R RUTHERFORD · fiscal years 2017 to 2021Named on NCT05531591, NCT05204940
- 4/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in late-life depressionR01MH114981 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Helen Lavretsky, Katherine L Narr · fiscal years 2017 to 2021Named on NCT05531591, NCT05204940
- 5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depressionR01MH114966 · NIMH · WASHINGTON UNIVERSITY · PI JOSHUA S SHIMONY · fiscal years 2017 to 2021Named on NCT05531591, NCT05204940
- 3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depressionR01MH114969 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MERYL A BUTTERS · fiscal years 2017 to 2021Named on NCT05204940
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:29 UTC. The ranking covers the 200 most relevant of 29 PubMed records, and a shared surname and initials can bring in a namesake. All 29 on PubMed
- Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial.Biol Psychiatry · 2013111 citationsRCR 4.1
- 109 citationsRCR 6.7
- 59 citationsRCR 3.3
- Effects of a Mobile and Web App (Thought Spot) on Mental Health Help-Seeking Among College and University Students: Randomized Controlled Trial.J Med Internet Res · 202051 citationsRCR 4.6
- Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.Psychopharmacology (Berl) · 200750 citationsRCR 1.7
- Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial.JAMA Psychiatry · 202542 citationsRCR 17.0
- Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial.Transl Psychiatry · 202131 citationsRCR 2.2
- Effects of Repetitive Transcranial Magnetic Stimulation on Working Memory Performance and Brain Structure in People With Schizophrenia Spectrum Disorders: A Double-Blind, Randomized, Sham-Controlled Trial.Biol Psychiatry Cogn Neurosci Neuroimaging · 202117 citationsRCR 1.3
- Randomized trial of a brief peer support intervention for individuals with schizophrenia transitioning from hospital to community.Schizophr Res · 202112 citationsRCR 1.4
- Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.Am J Psychiatry · 202411 citationsRCR 2.1